Cohen P
MRC Protein Phosphorylation Unit, Department of Biochemistry, MSI/WTB Complex, Dow Street, University of Dundee, Dundee, DD1 5EH, Scotland, UK.
Curr Opin Chem Biol. 1999 Aug;3(4):459-65. doi: 10.1016/S1367-5931(99)80067-2.
A number of small cell-permeant protein kinase inhibitors have been developed that have the potential for treating a variety of diseases. The basis for the specificity of several of these drugs has been elucidated and a number are undergoing human clinical trials.
已经开发出多种可透过细胞的小分子蛋白激酶抑制剂,它们具有治疗多种疾病的潜力。其中几种药物的特异性基础已得到阐明,并且有一些正在进行人体临床试验。